Form 8-K - Current report:
SEC Accession No. 0001104659-25-055992
Filing Date
2025-06-03
Accepted
2025-06-03 16:31:19
Documents
12
Period of Report
2025-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517069d1_8k.htm   iXBRL 8-K 35301
  Complete submission text file 0001104659-25-055992.txt   201186

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fencf-20250603.xsd EX-101.SCH 3014
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20250603_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20250603_pre.xml EX-101.PRE 22357
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2517069d1_8k_htm.xml XML 3674
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 251020127
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)